RxDoctor Payments Data

April Frater, MD

Family Medicine · Cary, NCNPI 1477050771

Payments from drug & device makers

$978in general payments, 2019–2025

Across 44 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$279
  • Novo Nordisk$247
  • AstraZeneca$114
  • Exact Sciences$66
  • Abbott$56
  • Eisai Inc.$55
  • plus $162 from 6 others

What the payments were for

  • Food & beverage$978100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$978 in reported general payments places this provider in the 65th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$24,010
Medicare patients
84
Services billed
267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin12$19,739
OzempicSemaglutide20$19,383
TrulicityDulaglutide11$10,539
Levothyroxine Sodium37$602
Gabapentin18$542
Rosuvastatin Calcium33$503
Albuterol Sulfate HfaAlbuterol Sulfate26$439
Atorvastatin Calcium50$395
Pantoprazole Sodium19$385
Losartan Potassium25$326
Omeprazole26$311
Venlafaxine Hcl ErVenlafaxine Hcl13$222
Amlodipine Besylate42$215
Trazodone Hcl21$200
Tamsulosin Hcl17$193

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$247$19,38320 claims
Lilly USA, LLCTrulicity$279$10,53911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Cary

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →